ARAGON PHARMACEUTICALS, INC.
Corporation · WILMINGTON, United States · LEI 549300DKBKXJKCBGVY27
LEI lapsed
Summary
ARAGON PHARMACEUTICALS, INC. is registered in the United States. Its legal form is Corporation. According to GLEIF, its ultimate parent is Johnson & Johnson (United States). That group has 209 subsidiaries with LEIs in 47 countries, 55 of them in the United States. The LEI was first issued on 30 Mar 2017 and the record was last updated on 4 Aug 2023. It has lapsed: renewal was due by 21 Oct 2022. AssetCensus found 3 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 21 Oct 2022 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent link rests on accounts for the period ending 3 Jan 2021, more than 24 months before this data release. The group may have changed since.
- The ultimate-parent relationship record was not renewed; it was last updated on 11 Sep 2023.
Company details
| Legal form | Corporation |
|---|---|
| Register | · Register website |
| Registration number | 4656680 |
| Registration authority | Division of Corporations, Department of State |
| Jurisdiction | United States (US-DE) |
| Registered address | C/O THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER 1209 ORANGE ST, 19801 WILMINGTON, United States |
| Headquarters address | 12780 El Camino Real, 92130 San Diego, United States |
| Category | company or other legal entity |
| Status | active |
| LEI | 549300DKBKXJKCBGVY27 |
| LEI status | lapsed |
| LEI first issued | 30 Mar 2017 |
| LEI record last updated | 4 Aug 2023 |
| Next LEI renewal | 21 Oct 2022 |
| Corroboration of the LEI record | fully corroborated |
Group membership
ARAGON PHARMACEUTICALS, INC. this entity
Relationship to the parent
| Ultimate parent | |
|---|---|
| Parent | Johnson & Johnson |
| Accounting period | 4 Jan 2020 to 3 Jan 2021 |
| Evidence | consolidated accounts |
| Corroboration | fully corroborated |
| Accounting standard | US GAAP |
| Relationship start | 7 Sep 2017 |
| Recorded at GLEIF since | 30 Mar 2017 |
| Last updated | 11 Sep 2023 |
| Record status | not renewed |
Parent not reported to GLEIF
- Direct parent: the parent information is not public, because of legal constraints, possible detriment, or because consent was not obtained.
Other names
- Farallon Biosciences, Inc · previous name